Benefits, Challenges and Potential Strategies of Open Source Health Economic Models

William C. N. Dunlop, Nicola Mason (), James Kenworthy and Ron L. Akehurst
Additional contact information
William C. N. Dunlop: Mundipharma International Ltd
Nicola Mason: BresMed Health Solutions
James Kenworthy: Mundipharma International Ltd
Ron L. Akehurst: BresMed Health Solutions

PharmacoEconomics, 2017, vol. 35, issue 1, No 10, 125-128

Keywords: Open Source; Health Technology Assessment; Qualitative Response; Health Economic Model; Health Technology Assessment Agency (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
http://link.springer.com/10.1007/s40273-016-0479-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-016-0479-8

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-016-0479-8

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().